South Korea has developed technology that can greatly extend a sub's range by allowing it to create hydrogen fuel cells on its own, according to a state-run defense research agency.
The Agency for Defense Development (ADD) announced that a new technology developed can generate high-purity hydrogen directly in submarines. High-purity hydrogen may be utilized as a fuel in submarine fuel cells.
Submarines also have problems charging their fuel cells since they are inefficient at storing energy and take a long time to charge. Furthermore, hydrogen may only be charged through different stations.
However, the newly-developed technology lets submarines produce high purity hydrogen autonomously through a fuel reforming method that utilizes methanol as a fuel.
Fuel reforming is a method of converting a chemical structure from the fuel's component and extracting the desired substance during the process.
The ADD stressed that the new technology does not require a separate hydrogen charging station and can reduce charging time, allowing for greater submarine range.


SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug
FDA Lifts REMS Requirement for CAR-T Cell Cancer Therapies
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off
Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record
Asian Markets Slip as AI Spending Fears Shake Tech, Wall Street Futures Rebound
Silver Prices Plunge in Asian Trade as Dollar Strength Triggers Fresh Precious Metals Sell-Off
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
Fed Governor Lisa Cook Warns Inflation Risks Remain as Rates Stay Steady
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices 



